BioHealth News Archive

U.S. government awards Novavax $1.6 billion for coronavirus vaccine | News | 1450 99.7 WHTC

U.S. government awards Novavax $1.6 billion for coronavirus vaccine | News | 1450 99.7 WHTC

CHICAGO (Reuters) - The U.S. government has awarded Novavax Inc $1.6 billion to cover testing and manufacturing of a potential vaccine for the novel…

Read More
Alexandria Real Estate Equities, Inc. Announces Pricing Of Upsized Public Offering Of 6,000,000 Shares Of Common Stock

Alexandria Real Estate Equities, Inc. Announces Pricing Of Upsized Public Offering Of 6,000,000 Shares Of Common Stock

PASADENA, Calif., July 6, 2020 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced the pricing of its upsized public…

Read More
REGENXBIO Provides Update on Progress of Clinical Programs for Rare Genetic Neurodegenerative Diseases

REGENXBIO Provides Update on Progress of Clinical Programs for Rare Genetic Neurodegenerative Diseases

ROCKVILLE, Md., July 8, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of…

Read More
Commentary: Washington wants to forfeit our best weapon against coronavirus | Columnists | elkodaily.com

Commentary: Washington wants to forfeit our best weapon against coronavirus | Columnists | elkodaily.com

Rep. Jan Schakowsky (D-IL) and several senior House lawmakers recently announced a plan to impose price controls and seize patents on any COVID-19 vaccines…

Read More
Meet the Researcher Leading NIH’s COVID-19 Vaccine Development Efforts – Government Executive

Meet the Researcher Leading NIH’s COVID-19 Vaccine Development Efforts – Government Executive

Asafe, effective vaccine is the ultimate tool needed to end the coronavirus disease 2019 (COVID-19) pandemic. Biomedical researchers are making progress every day towards…

Read More
Johns Hopkins calls new federal rules for international students ‘disturbing’ and ‘draconian’ – Baltimore Business Journal

Johns Hopkins calls new federal rules for international students ‘disturbing’ and ‘draconian’ – Baltimore Business Journal

Hopkins has the highest percentage of international students of any Maryland college.   {iframe}https://www.bizjournals.com/baltimore/news/2020/07/08/hopkins-opposes-federal-rule-international-student.html{/iframe}

Read More
Where Providence Ventures is investing millions — 17 portfolio companies including Protenus

Where Providence Ventures is investing millions — 17 portfolio companies including Protenus

Providence Ventures was founded in 2014 and manages $300 million of venture capital in two funds. The company is affiliated with Providence, a 51-hospital…

Read More

Johns Hopkins statement re: SEVP lawsuit filed today

BALTIMORE, July 10, 2020 /PRNewswire/ -- Johns Hopkins University filed suit in federal court Friday in an effort to stop a Trump administration rule…

Read More
Johns Hopkins’ Covid-19 map: Meet the team behind the leading resource – CNN

Johns Hopkins’ Covid-19 map: Meet the team behind the leading resource – CNN

(CNN) - If the year 2020 is good for anything, it's the lesson that during a crisis, anyone who builds a better mousetrap will…

Read More
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding | Emergent BioSolutions Inc.

Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding | Emergent BioSolutions Inc.

NEW YORK and GAITHERSBURG, Md. and NEW ORLEANS and LAFAYETTE, La., July 08, 2020 (GLOBE NEWSWIRE) -- The Mount Sinai Health System, Emergent BioSolutions…

Read More
APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401

APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401

VIENNA, AUSTRIA and GAITHERSBURG, MD, July 8, 2020 APEIRON Biologics AG (“APEIRON”), a private biotechnology company specializing in the discovery, development and commercialization of…

Read More
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine | GSK

GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine | GSK

GSK and Medicago today announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s…

Read More
Fueling an Innovation Ecosystem for Startups to Thrive – Tune In Today – Bendis to Moderate

Fueling an Innovation Ecosystem for Startups to Thrive – Tune In Today – Bendis to Moderate

BHI's own Rich Bendis will Moderate. Join us for a lively discussion between our region’s top innovators and connectors to hear about their efforts…

Read More
Fueling an Innovation Ecosystem for Startups to Thrive (Bendis to Moderate)

Fueling an Innovation Ecosystem for Startups to Thrive (Bendis to Moderate)

BHI's own Rich Bendis will Moderate. Join us for a lively discussion between our region’s top innovators and connectors to hear about their efforts…

Read More
The biotech IPO boom is becoming ‘historic’ as four more throw their hats in – Endpoints News

The biotech IPO boom is becoming ‘historic’ as four more throw their hats in – Endpoints News

Four more US biotechs filed to go pub lic Fri day as yet more com pa nies clam ber to get through a yawn…

Read More